Francesco B.
- Country
- Italy
- Department
- Opthalmology
Research Overview
- Phase III Randomized Double‑Masked Sham‑Controlled Trial of Intravitreal IL6‑Mab in Patients with Uveitic Macular Edema
- Phase 2 Randomized Placebo-Controlled Study of Subcutaneous ADX-038 in Adults With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Dose-ranging study of FWY003 in geographic atrophy secondary to age-related macular degeneration: randomized, double-masked, placebo-controlled trial in adults
Data & Insights
Has run more than one trial at 149 of 264 partner sites.
Specializations
Macular Degeneration Research
Primary focus on investigating treatments for various forms of macular degeneration, including both neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA). Expertise in evaluating novel therapeutic approaches and delivery systems for treating retinal conditions.
- Port Delivery System with Ranibizumab
- Anti-VEGF Therapeutics
- Complement Inhibition Studies
Retinal Disorders
Specialized in treating various retinal conditions, particularly diabetic macular edema (DME) and uveitic macular edema. Research encompasses innovative therapeutic approaches for diabetic retinopathy and retinal vein occlusion.
- Intravitreal Therapeutics
- Novel Drug Formulations
- Visual Acuity Outcomes
Ocular Surface Disorders
Investigation of treatments for various ocular surface conditions, including seasonal allergic conjunctivitis, neurotrophic keratopathy, and pediatric ocular anesthesia. Additional focus on glaucoma management and thyroid eye disease.
- Ophthalmic Solutions
- Pediatric Ophthalmology
- Visual Field Preservation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.